Drug
Gusperimus clinical trials
Also written Deoxyspergualin.
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2003 (2)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 1
Nippon Kayaku Co., Ltd. (3) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Nordic Pharma SAS (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
- One of Immunosuppressive Agents source
Studies
Open first, then newest update. How each study uses gusperimus is read from its arms, and is right about nine times in ten.
Testing it · 5
- Phase II Study on Gusperimus in Patients With Refractory Wegener's GranulomatosisCompletedPhase 2Nippon Kayaku Co., Ltd.NCT00530075Written as Gusperimus
- Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus NephritisCompletedPhase 1/2Nippon Kayaku Co., Ltd.NCT00709722Written as NKT-01
- Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 DiabetesCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00434850Written as Deoxyspergualin
- Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's GranulomatosisTerminatedPhase 3Nordic Pharma SASNCT01446211Written as Gusperimus + glucocorticoids
- Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic RejectionTerminatedNot applicableNippon Kayaku Co., Ltd.NCT01052259Written as Deoxyspergualin
Codes
What other systems call gusperimus · ClinicalTrials.gg INT003078
- MeSH (NLM) C037258gusperimusConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) UJ0ZJ76DO9GUSPERIMUSConfirmed FDA, NLM, Wikidata
- Wikidata Q10910504gusperimusConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C128052GusperimusOne source FDA
- DrugBank DB12692One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C037258 | gusperimus | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | UJ0ZJ76DO9 | GUSPERIMUS | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q10910504 | gusperimus | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C128052 | Gusperimus | One source FDA |
| DrugBank | DB12692 | — | One source Wikidata |
Also registered as deoxyspergualin (UNII 57F9XM233R) and gusperimus trihydrochloride (UNII QZS4144IO0).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.